WO1996002609A1 - Agent gonflant contenant un antioxydant - Google Patents
Agent gonflant contenant un antioxydant Download PDFInfo
- Publication number
- WO1996002609A1 WO1996002609A1 PCT/JP1995/001380 JP9501380W WO9602609A1 WO 1996002609 A1 WO1996002609 A1 WO 1996002609A1 JP 9501380 W JP9501380 W JP 9501380W WO 9602609 A1 WO9602609 A1 WO 9602609A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antioxidant
- weight
- sodium
- acid
- excipient
- Prior art date
Links
- 239000003963 antioxidant agent Substances 0.000 title claims abstract description 57
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 53
- 239000004604 Blowing Agent Substances 0.000 title claims abstract description 7
- 239000000843 powder Substances 0.000 claims abstract description 33
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims abstract description 32
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 22
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims abstract description 16
- 235000017557 sodium bicarbonate Nutrition 0.000 claims abstract description 16
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 230000003472 neutralizing effect Effects 0.000 claims abstract description 15
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 11
- 235000006708 antioxidants Nutrition 0.000 claims description 53
- 239000004088 foaming agent Substances 0.000 claims description 14
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 13
- 235000005487 catechin Nutrition 0.000 claims description 13
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 12
- 229950001002 cianidanol Drugs 0.000 claims description 12
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 11
- 150000001746 carotenes Chemical class 0.000 claims description 10
- 235000005473 carotenes Nutrition 0.000 claims description 10
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 9
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 5
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 5
- 239000000845 maltitol Substances 0.000 claims description 5
- 235000010449 maltitol Nutrition 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 5
- 229940035436 maltitol Drugs 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 229940046009 vitamin E Drugs 0.000 claims description 5
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical group C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 235000015165 citric acid Nutrition 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims 1
- 125000000837 carbohydrate group Chemical group 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 19
- 239000002253 acid Substances 0.000 description 9
- 239000000203 mixture Substances 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 7
- -1 for example Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 6
- 238000005187 foaming Methods 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 4
- 244000215068 Acacia senegal Species 0.000 description 4
- 229920000084 Gum arabic Polymers 0.000 description 4
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 4
- 239000000205 acacia gum Substances 0.000 description 4
- 235000010489 acacia gum Nutrition 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000007938 effervescent tablet Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 235000021552 granulated sugar Nutrition 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 3
- 244000269722 Thea sinensis Species 0.000 description 3
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PBTPTBMYJPCXRQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;hexadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCC(O)=O PBTPTBMYJPCXRQ-MGMRMFRLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000010726 Vigna sinensis Nutrition 0.000 description 1
- 244000042314 Vigna unguiculata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 229910001186 potin Inorganic materials 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/02—Anti-oxidant compositions; Compositions inhibiting chemical change containing inorganic compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/34—Anti-oxidant compositions; Compositions inhibiting chemical change containing plant or animal materials of unknown composition
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
- A23L2/395—Dry compositions in a particular shape or form
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/40—Effervescence-generating compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/42—Preservation of non-alcoholic beverages
- A23L2/44—Preservation of non-alcoholic beverages by adding preservatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/358—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to an antioxidant-containing blowing agent.
- antioxidants such as carotene, vitamin E, and catechin, bind to and stabilize the radicals generated in the living body and stop the radical chain reaction in the living body (radical force benger action).
- antioxidants such as carotene, vitamin E, and catechin
- antioxidant effect the effect of preventing catabolism of biological constituent proteins and the like (antioxidant effect) and of preventing carcinogenesis and the like (anticancer effect).
- anticancer effect It has also been reported to have an immunostimulatory effect, and is attracting attention as a food material or pharmaceutical material, particularly from the perspective of health food orientation.
- antioxidants have been difficult to formulate because of their solubility, stability against air (oxygen), light, heat, etc.
- an object of the present invention is to provide a new preparation, particularly a foaming agent, which contains the above-mentioned antioxidant substance uniformly and stably and has excellent solubility.
- the present invention relates to an antioxidant-containing powder or catechin (a water-soluble antioxidant) containing 0.2 to 20% by weight of an antioxidant (fat-soluble substance) (hereinafter simply referred to as “9”).
- Catechin-containing powder containing 10% or more of the following) 0.05 to 1596, sodium hydrogencarbonate and / or sodium carbonate 10 to 35596, neutralizing agent 10 to 7
- the present invention relates to a foaming agent containing an antioxidant, which contains 0% and an excipient of 30 to 55% as essential components.
- the invention relates to an antioxidant-containing powder 0.1 to 5.096 containing 0.5 to 10% of an antioxidant (liposoluble substance), sodium hydrogencarbonate and / or carbonic acid.
- the antioxidant-containing foaming agent and neutralizer containing 20 to 30% of sodium, 10 to 40% of a neutralizing agent, and 30 to 55% of an excipient as essential components.
- the antioxidant-containing foaming agent which is selected from linoleic acid, tartaric acid, citric acid, and ascorbic acid, and the antioxidant-containing foaming agent, which is an excipient or a saccharide selected from maltitol, sorbitol, and maltose.
- the present invention relates to the antioxidant-containing foaming agent, wherein the antioxidant and the antioxidant are at least one selected from the group consisting of carotenes, vitamins, and catechins.
- the antioxidant-containing foaming agent of the present invention is characterized in that the antioxidant is prevented from being oxidatively degraded and has good water solubility even in cold water.
- an antioxidant-containing powder which is one of the essential components of the formulation, for example, carotene, vitamin E, catechin, or the like is used as an antioxidant.
- the carotene is a precursor of vitamin A and has a provitamine A action, including ⁇ -, 9-1 and 7-potency.
- the vitamin ⁇ may be any one of ⁇ -, ⁇ -, 7-, and ⁇ -trimethyl phenol.
- both carotene and vitamins can be advantageously used in the present invention, whether they are natural products or synthetic products.
- ETC g epiga mouth techin gallate
- EC g tea polyphenol and lingopoly phenol
- EC g epigallocatechin
- EC epigate catechin Kin
- powders containing fat-soluble substances such as carotene and vitamin E can be obtained by dissolving the above-mentioned antioxidants in a suitable fat and oil, and then applying a suitable base for powdering.
- An agent (excipient) or a powder composed of a matrix using an emulsifier for solubilization or the like can be used.
- ordinary fats and oils for example, vegetable oils such as corn oil, peanut oil, essential oil, etc. can be used.
- a base (excipient) for the above-mentioned powdering ordinary ones, for example, lactose And sugars such as gum arabic and dextrin; and polysaccharides and proteins having a function as an emulsifier such as gum arabic and casein.
- the emulsifier for example, lecithin, glycerin fatty acid ester, sucrose fatty acid ester, calcium stearate lactylate, sorbitan fatty acid ester, propylene glycol fatty acid ester and the like can be used.
- the antioxidant-containing powder used in the present invention may contain, for example, oxidized substances such as L-ascorbic acid palmitate, vitamin (:, and enzyme-treated rutin) for the purpose of preventing oxidation of carotene and other antioxidants.
- Inhibitors can be added and compounded, and such compounding is more preferable.
- the matrix composition of the above-mentioned antioxidant-containing powder can be carried out according to a conventional method such as, for example, spray drying, and thus a desired powder having an arbitrary particle size can be obtained.
- a powder containing a water-soluble antioxidant such as catechin is concentrated, for example, after extracting the antioxidant with hot water or alcohol, and then concentrating the concentrate. Easy preparation by simply powdering according to the method it can.
- the compounding amount of the antioxidant-containing powder in the preparation of the present invention is as follows.
- antioxidants fat-soluble substances
- It is preferably contained in the range of 5 to 10% .Therefore, the remaining 99.8 to 80% should be combined with fats and oils and base or emulsifier components for pulverization or as required. It is an antioxidant component added and blended. In addition, usually, when the above antioxidant component is added and blended, it is preferably used in the range of about 0.5 to 20% in the obtained antioxidant-containing powder. In the case of a water-soluble antioxidant such as catechin, it is preferable that the powder contains 10% or more.
- the neutralizing agent refers to an acidic compound capable of generating carbon dioxide gas by neutralizing the above-mentioned sodium hydrogen carbonate and / or sodium carbonate.
- L-tartaric acid, cunic acid, lactic acid, d1-lingoic acid, fumaric acid, L-ascorbic acid and the like are included, and among them, d1-lingoic acid is preferred.
- the mixing ratio of the above foaming component in the preparation of the present invention is 10 to 35% of sodium hydrogen carbonate and / or sodium carbonate, preferably 20 to 30%, and a neutralizing agent. It is selected from the range of 10 to 70%, preferably 10 to 0.40%.
- sodium hydrogen carbonate is preferably selected from the range of 10 to 35%, preferably 20 to 30%, and sodium carbonate is 11 to 3196, Preferably, it is selected from the range of 20 to 26%.
- the above-mentioned neutralizing agent is used usually in an equivalent amount or more with respect to sodium hydrogencarbonate.
- the formulation of the present invention has an advantage that the water solubility is very good by adding and blending the foaming component, and the taste of the solution obtained by dissolving the same in water is also delicious.
- the above-mentioned balance between sodium hydrogencarbonate and the neutralizing agent if it is out of the above-mentioned specific range, it is difficult to obtain a product having satisfactory foamability and taste.
- each of the above-mentioned foaming components and various commonly available powder forms can be used in the present invention, and the particle size (particle size, size, etc.) is not limited at all. Breaks the matrix of antioxidant-containing powder when compressing powder A particle size that does not break is preferred. In other words, if a material with a high crystallinity is used as it is, the matrix of the antioxidant-containing powder is destroyed during tableting, and the antioxidant may be decomposed and lost by air, light, heat, etc. There is. The contribution of each component to the matrix's soil is determined by the intrinsic characteristics of the component, the size of the crystals, and the like. According to the research conducted by the present inventors, organic acids are used as neutralizing agents.
- the average crystal grain size is 250 to 3 even without crushing.
- the use of 5 proved to be the most preferred.
- large crystals such as granulated sugar are not preferred, and the use of saccharides and the like which are pulverized and granulated in the same manner as the above neutralizing agent is preferred.
- the sodium hydrogencarbonate and the sodium carbonate generally have a particle diameter of 100 to 150 wm.
- Carbohydrates as excipients include, for example, monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, xylitol, sonorebitol, manoleitol, mannitol, and erythr. Any of various ordinary sugars such as sugar alcohols such as litole can be used. Among them, maltitol, sorbitol and maltose are particularly preferred.
- the particle size of these excipients is The crystal may be in the form of powder or granule which is usually obtained, and is not particularly limited. In general, it is preferably about 180 to 350 m.
- the compounding ratio of the above-mentioned antioxidant-containing powder, the foaming component and the excipient must be selected from the above-mentioned specific range, whereby a desired foaming agent having the desired effect of the present invention can be obtained. Is done.
- the above-mentioned antioxidant-containing powder is below the above range, there is a disadvantage that the commercial value is lost, and when it exceeds the above range, there is a disadvantage that the tablet weight increases and the solubility becomes poor.
- the foaming agent of the present invention contains a predetermined amount of the above-mentioned specific component, and other general additives can also be added and blended.
- additives include thickeners, surfactants (emulsifiers), osmotic pressure regulators, electrolytes, sweeteners, flavors, pigments, pH regulators, and the like.
- the amounts of these additives are arbitrary, and are usually selected in such an amount that the original effect of each additive can be exerted, and the intended effect of the present invention is not hindered at all by such amounts. There is no fear.
- the blowing agent of the present invention can be prepared according to a conventional method using the above essential components and other additive components.
- a dry low-pressure tableting method can be exemplified. This involves weighing and mixing a predetermined amount of each component and comparing the mixture. It is a method of tableting with relatively low pressure. If the tableting pressure used here is too high, the matrix of the antioxidant-containing powder may be broken and the antioxidant may be susceptible to oxidation. It is better to select from an appropriate range because the characteristics deteriorate, usually about 0.2 to 0.35 ton / cm 2 , preferably 0.24 to 0.31 ton Z. cm 2 about rather good be selected from the range, 4. 0 to 6.
- parts means “parts by weight”.
- Granulated sugar 2000 mgd mono-Lingoic acid (using an average particle size of 250 to 350 m)
- the above 3-potency rotin powder is obtained by dissolving 4 parts of S-carotene in 32 parts of vegetable oil and fat, 2 parts of L-ascorbic acid, 2 parts of extracted tocopherol, 0.9 part of tea extract (containing tea polyphenol) and 0.1 part of L-ascorbic acid palmitic acid ester are matte based on gum arabic and sugars 58 parts. The composition was prepared and prepared.
- the tablets obtained had a tablet hardness of 5.lkp, a dissolution time of 1 minute and 10 seconds, and good stability. (Acceleration test after storage for 50 weeks and 2 weeks resulted in more than 90% ⁇ -force rotine Survival rate)
- the tablet hardness was measured as described above, and the dissolution time was measured by dissolving in 140 cc of cold water (8 ° C). 9
- the stability of Ichirotin is determined by extracting fl-potin in tablets with cyclohexane, and the absorption wavelength of carotene in the extract. (450 nm) was measured with an absorbance meter (using Hitachi U-3000), and the time-dependent force. displayed. Therefore, the higher the value, the less the loss due to oxidative decomposition of carotene.
- Other stability test items include swelling of packaging materials (by visual observation), discoloration of tablets (by using a color difference meter, manufactured by Tokyo Denshoku Co., Ltd., Kara-Ice liOEL TC-1), and taste change (sensory). Was selected and evaluated.
- the packaging material did not swell, the discoloration of the tablet was ⁇ E value ⁇ 3, and the change in taste was within the acceptable range o
- An effervescent tablet of the present invention comprising the components shown in Table 1 below (the values in the table are mg) was prepared.
- Vitamin E 5 Tea poly 7 ⁇ -nor extract ft 10 30 Phosphorus: ⁇ 3 ⁇ 4 800 300 500 1000
- L-ascorbin bacteria 100 500 100 200
- An effervescent tablet of the present invention comprising the components shown in Tables 2 and 3 below (the values in the tables are% by weight) was prepared.
- An effervescent tablet of the present invention comprising the components shown in Table 4 below (the values in the table are% by weight) was prepared.
- Example 21 the mixing ratio of the granulated sugar and maltitol used as carbohydrates was changed variously, and similarly, the tableting was continued until the tablet hardness reached the same value. Pressing with varying pressure to produce the effervescent tablet of the present invention
- the tableting pressure and dissolution time of each of the obtained tablets were measured.
- Table 5 shows that the higher the blending amount of maltitol, the lower the compression pressure achieved, and the shorter the dissolution time.
- a stable tablet containing an antioxidant and a high tablet An innovative formulation with hardness and short dissolution time is provided, which is useful in the food and pharmaceutical fields.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002171612A CA2171612C (en) | 1994-07-15 | 1995-07-12 | Antioxidant-containing effervescent composition |
JP50487796A JP3548865B2 (ja) | 1994-07-15 | 1995-07-12 | 抗酸化物質含有発泡剤 |
US08/617,841 US5919483A (en) | 1994-07-15 | 1995-07-12 | Antioxidant-containing effervescent composition |
EP95925102A EP0724004A4 (en) | 1994-07-15 | 1995-07-12 | INFLATABLE AGENT CONTAINING AN ANTIOXIDANT |
AU29357/95A AU689921B2 (en) | 1994-07-15 | 1995-07-12 | Antioxidant-containing effervescent composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP16378794 | 1994-07-15 | ||
JP6/163787 | 1994-07-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996002609A1 true WO1996002609A1 (fr) | 1996-02-01 |
Family
ID=15780706
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1995/001380 WO1996002609A1 (fr) | 1994-07-15 | 1995-07-12 | Agent gonflant contenant un antioxydant |
Country Status (9)
Country | Link |
---|---|
US (1) | US5919483A (ja) |
EP (1) | EP0724004A4 (ja) |
JP (1) | JP3548865B2 (ja) |
KR (1) | KR100361389B1 (ja) |
CN (1) | CN1086728C (ja) |
AU (1) | AU689921B2 (ja) |
CA (1) | CA2171612C (ja) |
TW (1) | TW367357B (ja) |
WO (1) | WO1996002609A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100456578B1 (ko) * | 2001-11-30 | 2004-11-10 | 박희재 | 동력조향장치용 입력축 검사기 및 그 검사방법 |
JP2018016776A (ja) * | 2016-07-29 | 2018-02-01 | ミヨシ油脂株式会社 | 抗酸化剤、抗酸化剤を含有する油脂組成物およびこれを含有する油性食品 |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2204599A1 (en) * | 1995-09-07 | 1997-03-13 | Otsuka Pharmaceutical Co., Ltd. | Low-pressure tableted effervescent preparation |
US6660049B1 (en) | 1996-07-31 | 2003-12-09 | Natural Soda Aala, Inc. | Process for control of crystallization of inorganics from aqueous solutions |
US6589555B2 (en) | 1999-12-29 | 2003-07-08 | Mahendra Pandya | Effervescent vitaceutical compositions and related methods |
US7125859B2 (en) * | 2003-07-24 | 2006-10-24 | Materials Evolution And Development Usa, Inc. | Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof |
US7785640B2 (en) * | 2004-01-16 | 2010-08-31 | Amerilab Technologies, Inc. | Effervescent composition including cranberry extract |
US20080044540A1 (en) * | 2004-03-19 | 2008-02-21 | Hirotsugu Kido | Anti-Degradation Agent |
US20060039972A1 (en) * | 2004-08-19 | 2006-02-23 | Mary Aldritt | Effervescent composition including a grape-derived component |
JP2007254339A (ja) * | 2006-03-22 | 2007-10-04 | Takasago Internatl Corp | ロックイン型粉末 |
KR100801891B1 (ko) | 2006-11-02 | 2008-02-12 | 한상진 | 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물 |
EP2213304A1 (en) * | 2007-10-03 | 2010-08-04 | ASAHI BREWERIES, Ltd. | Granule, tablet, and their production methods |
US9474292B1 (en) | 2010-09-16 | 2016-10-25 | EvoSci Biotech LLC | Nutritional powder including brewer's yeast, aronia extract, and cranberry extract for animals |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051104A (ja) * | 1983-08-30 | 1985-03-22 | Ajinomoto Co Inc | ビタミンe含有水性液剤 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2083997A (en) * | 1980-09-16 | 1982-04-07 | Bp Nutrition | Animal feed supplement |
JPS59166585A (ja) * | 1983-03-10 | 1984-09-19 | Osaka Chem Lab | 抗酸化剤 |
DE3517916A1 (de) * | 1985-05-18 | 1986-11-20 | Krüger GmbH & Co KG, 5060 Bergisch Gladbach | Vitamin-e-brausetabletten |
-
1995
- 1995-07-12 JP JP50487796A patent/JP3548865B2/ja not_active Expired - Fee Related
- 1995-07-12 KR KR1019960701330A patent/KR100361389B1/ko not_active IP Right Cessation
- 1995-07-12 EP EP95925102A patent/EP0724004A4/en not_active Withdrawn
- 1995-07-12 CA CA002171612A patent/CA2171612C/en not_active Expired - Fee Related
- 1995-07-12 CN CN95190852A patent/CN1086728C/zh not_active Expired - Fee Related
- 1995-07-12 WO PCT/JP1995/001380 patent/WO1996002609A1/ja not_active Application Discontinuation
- 1995-07-12 AU AU29357/95A patent/AU689921B2/en not_active Ceased
- 1995-07-12 US US08/617,841 patent/US5919483A/en not_active Expired - Fee Related
- 1995-07-14 TW TW084107309A patent/TW367357B/zh active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6051104A (ja) * | 1983-08-30 | 1985-03-22 | Ajinomoto Co Inc | ビタミンe含有水性液剤 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100456578B1 (ko) * | 2001-11-30 | 2004-11-10 | 박희재 | 동력조향장치용 입력축 검사기 및 그 검사방법 |
JP2018016776A (ja) * | 2016-07-29 | 2018-02-01 | ミヨシ油脂株式会社 | 抗酸化剤、抗酸化剤を含有する油脂組成物およびこれを含有する油性食品 |
Also Published As
Publication number | Publication date |
---|---|
AU689921B2 (en) | 1998-04-09 |
CA2171612C (en) | 2005-02-01 |
EP0724004A4 (en) | 1996-12-27 |
AU2935795A (en) | 1996-02-16 |
KR960704994A (ko) | 1996-10-09 |
CA2171612A1 (en) | 1996-02-01 |
TW367357B (en) | 1999-08-21 |
EP0724004A1 (en) | 1996-07-31 |
US5919483A (en) | 1999-07-06 |
KR100361389B1 (ko) | 2003-01-24 |
JP3548865B2 (ja) | 2004-07-28 |
CN1135232A (zh) | 1996-11-06 |
CN1086728C (zh) | 2002-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7141542B2 (ja) | 微発泡性バッカル錠およびその調製方法 | |
JP4213867B2 (ja) | 経口用カルシウム組成物の調製方法 | |
JP4842824B2 (ja) | コエンザイムq10含有組成物 | |
KR100256150B1 (ko) | 장내 부패산물 생성을 억제시키는 음료 조성물 | |
WO1996002609A1 (fr) | Agent gonflant contenant un antioxydant | |
CA2200568C (fr) | Association therapeutique vitamino-calcique sous forme galenique unitaire de comprimes, son procede d'obtention et son utilisation | |
WO2006035900A1 (ja) | コエンザイムq10含有乳化組成物 | |
WO2008053920A1 (fr) | Composition granulaire contenant une substance physiologiquement active et son procédé de production | |
JP2019104712A (ja) | 阿膠含有粉末、これを含む錠剤及び食品、並びに阿膠含有粉末の製造方法 | |
EP3165218A1 (en) | Water dispersible granulates containing oxidized or reduced forms of coenzyme q10 | |
WO2006003909A1 (ja) | 脂肪燃焼促進剤 | |
JP2006016390A (ja) | プロアントシアニジン含有組成物 | |
WO1997009037A1 (fr) | Preparation effervescente se presentant sous forme de comprimes produits a basse pression | |
JPS6119230B2 (ja) | ||
WO2005082417A1 (es) | Polvo de xilitol directamente comprimible | |
US10966920B2 (en) | Effervescent tablets that include crystalline sugar binder and methods of making the same | |
JP2003310212A (ja) | 水分散性又は水溶解性のバナバ葉抽出物組成物 | |
JP5759047B1 (ja) | ウコン中の有用成分を含有する低水分系組成物 | |
KR100769581B1 (ko) | 탄산 캔디 함유 세정용 화장료 조성물 | |
JP5306626B2 (ja) | 粉末製剤並びにそれを用いた食品素材及び化粧品素材 | |
EP0972513B1 (en) | Process for preparing emulsified powder | |
JP6682385B2 (ja) | 固形状組成物 | |
Tokusoglu | Food tablet manufacturing strategies: Research data on effervescent food supplements | |
JP3515954B2 (ja) | プロポリス加工食品 | |
JPH0940574A (ja) | ダイエット組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 95190852.9 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN JP KR US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2171612 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08617841 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019960701330 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995925102 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1995925102 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995925102 Country of ref document: EP |